Is DXCM or UTHR cheaper?

On trailing earnings, UTHR is cheaper: DXCM trades at a 32.21 P/E and UTHR at 20.18.

Which has grown faster, DXCM or UTHR?

Over the past five years, DXCM grew revenue faster — DXCM at a 18.91% CAGR versus UTHR at 16.05%.

Is DXCM or UTHR more profitable?

UTHR runs the higher net margin — DXCM at 19.31% versus UTHR at 40.61%.

Which has been the better investment, DXCM or UTHR?

Over the past 10-year, UTHR delivered the higher annualized total return — DXCM at 15.40% versus UTHR at 17.22%. Past performance doesn't predict future results.

DexCom, Inc. (DXCM) vs United Therapeutics Corporation (UTHR)

UTHR leads on 9 of 16 compared metrics.

A side-by-side comparison of DexCom, Inc. and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

United Therapeutics Corporation

$23.17B

$545.96Healthcare

Total return — DXCM vs UTHR

growth of $100 · last 21y

DXCM +2463.6%UTHR +2229.7%DXCM compounded faster

DXCM UTHR

DXCM vs UTHR: by the numbers

•DXCM is the larger company ($29.08B vs $23.17B market cap).
•UTHR trades at the lower earnings multiple (20.18 vs 32.21 P/E).
•UTHR converts more revenue to profit (40.61% vs 19.31% net margin).
•DXCM grew revenue faster over the past five years (18.91% vs 16.05% CAGR).

Which is better, DXCM or UTHR?

Metric tally: DXCM 7 · UTHR 9

It depends on what you're optimizing for:

ValueUTHR(lower P/E)

GrowthDXCM(faster 5Y revenue CAGR)

QualityDXCM(higher ROIC)

Valuation

Metric	DXCM	UTHR
P/E ratio	32.21	20.18●
Forward P/E	24.42	16.48●
P/S ratio	6.16●	8.13
P/B ratio	10.03	4.37●
PEG ratio	0.66●	1.16
EV / EBITDA	20.28	14.41●
FCF yield	4.82%●	3.95%

Profitability

Metric	DXCM	UTHR
Gross margin	61.84%	86.58%●
Operating margin	21.45%	45.34%●
Net margin	19.31%	40.61%●
ROE	31.47%●	21.82%
ROIC	16.61%●	16.14%

Growth (annualized)

Metric	DXCM	UTHR
Revenue CAGR (5Y)	18.91%●	16.05%
EPS CAGR (5Y)	10.31%	20.93%●
FCF CAGR (5Y)	43.37%●	12.12%
Total return CAGR (5Y)	-5.51%	24.96%●

Frequently asked

Which is better, DXCM or UTHR?: It depends on your goal. value: UTHR (lower P/E); growth: DXCM (faster 5Y revenue CAGR); quality: DXCM (higher ROIC). Across all compared metrics, UTHR leads 9 to 7.
Is DXCM or UTHR cheaper?: On trailing earnings, UTHR is cheaper: DXCM trades at a 32.21 P/E and UTHR at 20.18.
Which has grown faster, DXCM or UTHR?: Over the past five years, DXCM grew revenue faster — DXCM at a 18.91% CAGR versus UTHR at 16.05%.
Is DXCM or UTHR more profitable?: UTHR runs the higher net margin — DXCM at 19.31% versus UTHR at 40.61%.
Which has been the better investment, DXCM or UTHR?: Over the past 10-year, UTHR delivered the higher annualized total return — DXCM at 15.40% versus UTHR at 17.22%. Past performance doesn't predict future results.

Go deeper

Full DXCM analysis Full UTHR analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio United Therapeutics P/E ratio DexCom dividend yield United Therapeutics dividend yield DexCom ROE United Therapeutics ROE DexCom operating margin United Therapeutics operating margin DexCom revenue growth United Therapeutics revenue growth DexCom free cash flow United Therapeutics free cash flow

DexCom & United Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.